AA |
Arachidonic acid |
ABTS+
|
2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonicacid) radical cation assay |
AChE |
Acetylcholinesterase |
AD |
Alzheimer’s disease |
ADMET |
Absorption, distribution, metabolism, excretion, toxicity |
AP-1 |
Activator protein 1 |
BChE |
Butyrylcholinesterase |
CA-II |
Carbonic anhydrase II |
COX |
Cyclooxygenase |
DPPH |
Diphenylpicrylhydrazyl assay |
FRAP |
Antioxidant power assay |
IC50
|
Half-maximal inhibitory concentration |
IFN-γ |
Interferon-gamma |
iNOS |
Nitric oxide synthase |
IZ |
Inhibition zone |
LOX |
Lipoxygenase |
LPS |
Lipopolysaccharide |
LTs |
Leukotrienes |
NET |
O2−• radical scavenging assay |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
pdb |
Protein data bank |
PMNs |
Polymorphonuclear leukocytes |
PGs |
Prostaglandins |
QSAR |
Quantitative structure–activity relationship |
SAR |
Structure–activity relationship |
STZHFD |
Streptozocin and high-fat diet |
TNF-α |
Tumor necrosis factor-alpha |
TRAP |
ROO• radical scavenging assay |
TRP |
Transient receptor potential |
TRPA1 |
Transient receptor potential channels of ankyrin type-1 |
TRPV1 |
Transient receptor potential channels of vanilloid type-1 |
Tx |
Thromboxanes |
URAT1 |
Urate transporter 1 |
XOD |
Xanthine oxidase |
11β-HSD |
11β-hydroxysteroid dehydrogenase |